18-09-2020
Mark Van Scyoc / Shutterstock.com
The United States Patent and Trademark Office (USPTO) has unveiled a deferred-fee provisional patent application pilot programme for inventions that combat COVID-19.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
USPTO, COVID-19, provisional patent application, inventions, pilot programme, FDA, innovation, certificate, payment, scientific information
USPTO increases ‘fast-track’ examinations limit to 15,000
27-09-2021
USPTO issues 11 millionth patent
12-05-2021
‘Suspect’ China filings driven by govt subsidies and targets, says USPTO
14-01-2021
USPTO launches COVID-19 patent platform
05-05-2020
USPTO offers COVID-19 relief; CJEU restricts activities
17-03-2020
